Precision BioSciences

Cindy Atwell, VP, Business Development and Alliance Management
Durham, NC
(NASDAQ: DTIL)
Precision BioSciences is dedicated to improving life through its proprietary genome editing platform, “ARCUS.” Precision leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and create healthy and sustainable food and agriculture solutions. Precision is actively developing product candidates in three innovative areas: allogeneic CAR-T immunotherapy, in vivo gene correction, and food.
www.precisionbiosciences.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions